Find News

Filter articles

Applied Filters

Showing 81 to 90 of 122 results

Piper Alderman adds special counsel in Australia


Australia-based law firm Piper Alderman has hired Julian Grover as a special counsel in the firm’s intellectual property practice.

NGOs urge Obama to change stance on LDCs patent waiver


US President Barack Obama has been urged by several non-government organisations to permanently exempt the world’s least developed countries from having to grant patents for pharmaceutical products.

D’Arcy v Myriad: Australia’s High Court deals blow to natural product patents


Australia’s highest court has said that naturally occurring nucleic acid molecules are not patentable, overturning a lower court ruling.

TPP: Australia succeeds in limiting data exclusivity to five years

Australia, US07-10-2015

Australia’s government has said the period of data exclusivity available for biological drugs in the Trans-Pacific Partnership will be five years, despite pressure from the US to extend it to 12.

Global Pharma IP Forum: Japan’s Supreme Court Teva decision a ‘death sentence’


A Japanese lawyer has described a ruling by the Supreme Court of Japan as a “death sentence” for product-by-process patents and said it is a good time for drugs companies to challenge rivals’ patents.

Pfizer’s Hospira buyout approved in Australia and Canada

Australia, Canada18-08-2015

Pfizer’s $17 billion buyout of Hospira has been approved in Canada and Australia after the countries’ competition bureaus approved the deal.

Pharma patent filings peaked sharply in 2014, report shows

China, International, US04-08-2015

Worldwide applications for pharmaceutical patents “peaked sharply” in 2014, reaching around 28,000, a report has shown.

Biosimilars market value could triple by 2020, says report


The market value for biosimilars around the world could reach $20 billion by the end this year and that figure could nearly triple by 2020, according to a report.

Novartis and Philips talk patents and innovation at Thomson Reuters event


At a Thomson Reuters event in Paris on Thursday to celebrate the European companies featured on its list of top 100 global innovators, panellists including Novartis and Philips discussed the nature of innovation and how to encourage it.

Market for fighting fake pharma packets to soar in value, report says


The global market for products seeking to tackle counterfeit pharmaceutical and cosmetics packaging will reach more than $80 billion by 2020, according to a report.

Showing 81 to 90 of 122 results